Business
Indoor Harvest Supports Actions by Justice Department
Indoor Harvest Supports Actions by Justice Department.
About this update from Indoor Harvest Corp.
[{"type":"text","content":"\n\n HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Indoor Harvest Corp (OTCQB:INQD), a developer of personalized cannabis medicines and a provider of advanced cultivation methods and processes for the cannabis industry, provides comments on recent news that Attorney General Jeff Sessions intends to end Obama era policies regarding enforcement of cannabis.\n On August 29, 2013, the U.S. Department of Justice (“DOJ”) issued a memorandum (“Cole Memo”) providing that where states and local governments enact laws authorizing cannabis-related use, and implement strong and effective regulatory and enforcement systems, the federal government will rely upon states and local enforcement agencies to address cannabis activity through the enforcement of their own state and local narcotics laws. It is expected that Attorney General Jeff Sessions and the DOJ will suspend the Cole Memo later today. While the Cole Memo has allowed cannabis business to flourish in the U.S., it was only a temporary solution. The actions by the DOJ we believe will put more pressure on Congress to enact legislation that will resolve the current conflict between State and Federal law. In September, the Marijuana Effective Drug Study Act of 2017 (MEDS Act) was introduced by Sen. Hatch, a Republican from Utah, which we believe if passed would have a positive impact on the Company’s business plans and efforts. Today, 29 states, the District of Columbia and Guam allow their citizens to use medical cannabis through de-criminalization. Voters in the states of Alaska, California, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington have legalized cannabis for adult recreational use. The Company believes this move, while temporarily disrupting the markets and shaking investor confidence, is ultimately the right move to make. Currently there is overwhelming public support for some form of cannabis legalization for medical use. While it is yet to be seen whether these actions will impede the Company’s immediate business plans, the Company’s primary business goal is to use the technology, science and relationships developed by the Company to become a registered producer of cannabis under the Controlled Substance Act pursuant to the policy statement issued under Federal Register Vol. 81 and subsection 823(a)(1) of the Controlled S...